Fate Therapeutics Reports First Quarter 2015 Financial Results

Go back to Fate Therapeutics Reports First Quarter 2015 Financial Results
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.66 -0.06 (2.21%)
Previous Close $2.72    52 Week High $4.76 
Open $2.83    52 Week Low $1.46 
Day High $2.85    P/E N/A 
Day Low $2.64    EPS $-1.91 
Volume 753,696